OMGs: A multi-agent system supporting MDT decision-making across the ovarian tumour care continuum

Fuente: arXiv
Enregistré dans:
Détails bibliographiques
Auteurs principaux: Zhang, Yangyang, Wang, Zilong, Xu, Jianbo, Chen, Yongqi, Han, Chu, Zhang, Zhihao, Liu, Shuai, Li, Hui, Zhang, Huiping, Liu, Ziqi, Chen, Jiaxin, Zhu, Jun, Feng, Zheng, Wen, Hao, Ju, Xingzhu, Zhong, Yanping, Zhang, Yunqiu, Duan, Jie, Li, Jun, Li, Dongsheng, Wang, Weijie, Zhu, Haiyan, Jiang, Wei, Wu, Xiaohua, Wang, Shuo, Li, Haiming, Guo, Qinhao
Format: Preprint
Publié: 2026
Sujets:
Accès en ligne:
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
_version_ 1866918338361294848
author Zhang, Yangyang
Wang, Zilong
Xu, Jianbo
Chen, Yongqi
Han, Chu
Zhang, Zhihao
Liu, Shuai
Li, Hui
Zhang, Huiping
Liu, Ziqi
Chen, Jiaxin
Zhu, Jun
Feng, Zheng
Wen, Hao
Ju, Xingzhu
Zhong, Yanping
Zhang, Yunqiu
Duan, Jie
Li, Jun
Li, Dongsheng
Wang, Weijie
Zhu, Haiyan
Jiang, Wei
Wu, Xiaohua
Wang, Shuo
Li, Haiming
Guo, Qinhao
author_facet Zhang, Yangyang
Wang, Zilong
Xu, Jianbo
Chen, Yongqi
Han, Chu
Zhang, Zhihao
Liu, Shuai
Li, Hui
Zhang, Huiping
Liu, Ziqi
Chen, Jiaxin
Zhu, Jun
Feng, Zheng
Wen, Hao
Ju, Xingzhu
Zhong, Yanping
Zhang, Yunqiu
Duan, Jie
Li, Jun
Li, Dongsheng
Wang, Weijie
Zhu, Haiyan
Jiang, Wei
Wu, Xiaohua
Wang, Shuo
Li, Haiming
Guo, Qinhao
contents Ovarian tumour management has increasingly relied on multidisciplinary tumour board (MDT) deliberation to address treatment complexity and disease heterogeneity. However, most patients worldwide lack access to timely expert consensus, particularly in resource-constrained centres where MDT resources are scarce or unavailable. Here we present OMGs (Ovarian tumour Multidisciplinary intelligent aGent System), a multi-agent AI framework where domain-specific agents deliberate collaboratively to integrate multidisciplinary evidence and generate MDT-style recommendations with transparent rationales. To systematically evaluate MDT recommendation quality, we developed SPEAR (Safety, Personalization, Evidence, Actionability, Robustness) and validated OMGs across diverse clinical scenarios spanning the care continuum. In multicentre re-evaluation, OMGs achieved performance comparable to expert MDT consensus ($4.45 \pm 0.30$ versus $4.53 \pm 0.23$), with higher Evidence scores (4.57 versus 3.92). In prospective multicentre evaluation (59 patients), OMGs demonstrated high concordance with routine MDT decisions. Critically, in paired human-AI studies, OMGs most substantially enhanced clinicians' recommendations in Evidence and Robustness, the dimensions most compromised when multidisciplinary expertise is unavailable. These findings suggest that multi-agent deliberative systems can achieve performance comparable to expert MDT consensus, with potential to expand access to specialized oncology expertise in resource-limited settings.
format Preprint
id arxiv_https___arxiv_org_abs_2602_13793
institution arXiv
publishDate 2026
record_format arxiv
spellingShingle OMGs: A multi-agent system supporting MDT decision-making across the ovarian tumour care continuum
Zhang, Yangyang
Wang, Zilong
Xu, Jianbo
Chen, Yongqi
Han, Chu
Zhang, Zhihao
Liu, Shuai
Li, Hui
Zhang, Huiping
Liu, Ziqi
Chen, Jiaxin
Zhu, Jun
Feng, Zheng
Wen, Hao
Ju, Xingzhu
Zhong, Yanping
Zhang, Yunqiu
Duan, Jie
Li, Jun
Li, Dongsheng
Wang, Weijie
Zhu, Haiyan
Jiang, Wei
Wu, Xiaohua
Wang, Shuo
Li, Haiming
Guo, Qinhao
Computation and Language
Ovarian tumour management has increasingly relied on multidisciplinary tumour board (MDT) deliberation to address treatment complexity and disease heterogeneity. However, most patients worldwide lack access to timely expert consensus, particularly in resource-constrained centres where MDT resources are scarce or unavailable. Here we present OMGs (Ovarian tumour Multidisciplinary intelligent aGent System), a multi-agent AI framework where domain-specific agents deliberate collaboratively to integrate multidisciplinary evidence and generate MDT-style recommendations with transparent rationales. To systematically evaluate MDT recommendation quality, we developed SPEAR (Safety, Personalization, Evidence, Actionability, Robustness) and validated OMGs across diverse clinical scenarios spanning the care continuum. In multicentre re-evaluation, OMGs achieved performance comparable to expert MDT consensus ($4.45 \pm 0.30$ versus $4.53 \pm 0.23$), with higher Evidence scores (4.57 versus 3.92). In prospective multicentre evaluation (59 patients), OMGs demonstrated high concordance with routine MDT decisions. Critically, in paired human-AI studies, OMGs most substantially enhanced clinicians' recommendations in Evidence and Robustness, the dimensions most compromised when multidisciplinary expertise is unavailable. These findings suggest that multi-agent deliberative systems can achieve performance comparable to expert MDT consensus, with potential to expand access to specialized oncology expertise in resource-limited settings.
title OMGs: A multi-agent system supporting MDT decision-making across the ovarian tumour care continuum
topic Computation and Language
url https://arxiv.org/abs/2602.13793